NCT06964581

Brief Summary

Non-Inferiority Study, Post-Market Clinical Investigation with a Device, Single-Blind Randomized Controlled Trial in a Cohort of Patients Diagnosed with Multiple Sclerosis (MS). The aim of the study is to assess whether a computer-based cognitive treatment delivered via telerehabilitation produces effects from T0 to T1 that are not inferior to those of an in-person treatment on sustained attention in a cohort of patients with MS. The secondary objective is to evaluate the effects of telerehabilitation compared to the same treatment delivered in person on attentional shifting, memory, executive functions, and daily functioning (including cognitive fatigue, quality of life, and mood) in patients with MS.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 8, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2025

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 9, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

May 9, 2025

Status Verified

April 1, 2025

Enrollment Period

2.2 years

First QC Date

April 30, 2025

Last Update Submit

April 30, 2025

Conditions

Keywords

telerehabilitationmultiple sclerosiscognitive disorders

Outcome Measures

Primary Outcomes (1)

  • Paced Auditory Serial Addition Task (PASAT)

    In the Paced Auditory Serial Addition Task (PASAT), the patient listens to a recorded voice reading a series of numbers at regular intervals. They must mentally add each number to the one immediately preceding it and respond orally. The test assesses sustained attention, working memory, and processing speed. The maximum score, usually 60, corresponds to the number of correct responses, with higher scores indicating better cognitive performance.

    The test is administered before the treatment, then after eight weeks of treatment, and finally two months after the end of the treatmen

Secondary Outcomes (10)

  • Trail Making Test Part A (TMT-A)

    The test is administered before the treatment, then after eight weeks of treatment, and finally two months after the end of the treatmen

  • Trail Making Test Part B (TMT-B)

    The test is administered before the treatment, then after eight weeks of treatment, and finally two months after the end of the treatmen

  • Symbol Digit Modalities Test

    The test is administered before the treatment, then after eight weeks of treatment, and finally two months after the end of the treatmen

  • Modified Five Point Test (MFPT)

    The test is administered before the treatment, then after eight weeks of treatment, and finally two months after the end of the treatmen

  • "Learning" subtest of the Rivermead Behavioural Memory Test-3 (RBMT-3)

    The test is administered before the treatment, then after eight weeks of treatment, and finally two months after the end of the treatmen

  • +5 more secondary outcomes

Study Arms (2)

Telerehabilitation

EXPERIMENTAL

Three hours of cognitive rehabilitation per week, carried out independently and remotely using a computerized device, which is pre-programmed according to the patient's specific needs.

Behavioral: Cognitive treatment delivered via telerehabilitation.

In-person treatment

ACTIVE COMPARATOR

Three hours of in-person cognitive rehabilitation per week using a computerized device. The participant will perform cognitive exercises on the computerized device in the presence of the therapist, who will activate the device (using credentials specifically created for them) and select the appropriate activity to administer at each session.

Behavioral: In-person cognitive treatment.

Interventions

Three hours of cognitive rehabilitation per week, carried out independently and remotely using a computerized device, which is pre-programmed according to the patient's specific needs.

Telerehabilitation

Three hours of in-person cognitive rehabilitation per week using a computerized device. The participant will perform cognitive exercises on the computerized device in the presence of the therapist, who will activate the device (using credentials specifically created for them) and select the appropriate activity to administer at each session.

In-person treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of relapsing-remitting multiple sclerosis (RRMS), or primary progressive (PPMS) or secondary progressive (SPMS), defined by at least 3-6 months.
  • Age between 18 and 65 years.
  • Expanded Disability Status Scale (EDSS) between 3 and 5 to include patients with overall neurological disability from mild to moderate.
  • Presence of one or more of the following cognitive disorders (reported by the patient and subsequently confirmed through the Oxford Cognitive Screen-OCS):
  • Memory disorders
  • Attention disorders
  • Executive function disorders
  • Availability of internet at the patient's home necessary for the tele-rehabilitation procedures.
  • Adequate visual and auditory abilities to use the rehabilitation device.

You may not qualify if:

  • Presence of other neurological conditions;
  • Psychiatric disorders in medical history;
  • Alcohol and/or drug abuse;
  • Presence of uncorrected severe visual deficits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione

Verona, verona, 37134, Italy

RECRUITING

MeSH Terms

Conditions

Multiple SclerosisCognitive Dysfunction

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Valentina Varalta, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 30, 2025

First Posted

May 9, 2025

Study Start

February 8, 2023

Primary Completion

April 22, 2025

Study Completion

September 30, 2025

Last Updated

May 9, 2025

Record last verified: 2025-04

Locations